Physician profile
Andrew Lederman
NPI 1801162862
$4,179.77
in general payments reported to CMS, 2019-2025
10 companies · $786 in 2025
The $786 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $191 · 2020: $539 · 2021: $1,088 · 2022: $609 · 2023: $258 · 2024: $710 · 2025: $786.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,633 · Travel and Lodging: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,632.77 |
| Travel and Lodging | $120.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,445.89 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Boston Scientific Corporation | $1,178.69 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Vertos Medical, INC. | $376.09 | 2021-2024 | Mild Device Kit |
| Saluda Medical Americas, INC. | $305.85 | 2025 | Evoke |
| Medtronic USA, INC. | $277.40 | 2019-2020 | |
| Relievant Medsystems, INC. | $260.56 | 2021-2022 | |
| Spr Therapeutics, INC | $187.02 | 2020-2024 | Sprint Pns System |
| Stryker Corporation | $84.70 | 2024 | Optablate, Spinejack |
| Abbott Laboratories | $46.52 | 2021 | |
| Fisher & Paykel Healthcare INC | $17.05 | 2024 | Fisher & Paykel Healthcare |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Lederman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.